Delcath

Delcath Systems, Inc. CHEMOSAT Added to ESMO–EURACAN Guidelines for Uveal Melanoma

Delcath Systems Secures Key Guideline Recognition for CHEMOSAT in Uveal Melanoma Treatment Delcath Systems, Inc., an interventional oncology company specializing in liver-directed cancer therapies, has announced a significant milestone for its proprietary CHEMOSAT® Hepatic Delivery System for Melphalan. The therapy,…

Read MoreDelcath Systems, Inc. CHEMOSAT Added to ESMO–EURACAN Guidelines for Uveal Melanoma
CareTrust

CareTrust REIT Reports $119 Million in New Investments and Strengthens Acquisition Pipeline

CareTrust REIT, Inc. Expands Investment Activity with $119 Million in New Deals CareTrust REIT, (“CareTrust” or the “Company”) has announced the successful closing of two significant investment transactions totaling approximately $119 million, both effective April 1, 2026. These deals underscore…

Read MoreCareTrust REIT Reports $119 Million in New Investments and Strengthens Acquisition Pipeline
Xponential

Xponential Fitness Explores Strategic Options to Enhance Shareholder Value

Xponential Fitness Launches Strategic Review and Strengthens Board with New Appointment Xponential Fitness, a leading global franchisor of boutique health and wellness brands, has announced a comprehensive review of strategic alternatives aimed at maximizing shareholder value. The initiative underscores the…

Read MoreXponential Fitness Explores Strategic Options to Enhance Shareholder Value